The Patent Finder

Nobel Biosciences LLC

Also on record
Records under this name other than patents Nobel Biosciences LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Nobel Biosciences LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,175,077Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
Lapsed on the fee record
Ended Nov 3, 2019 · USPTO record
Lapsed on the fee recordEnded Nov 3, 2019USPTO record
US 7,994,278Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
Lapsed on the fee record
Ended Aug 9, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 9, 2019USPTO record
US 6,805,882Therapeutic fractions of sources of HCG
Term ended
Term ended Apr 30, 2018 · USPTO record
Term endedTerm ended Apr 30, 2018USPTO record
US 6,699,834Method for treating cancer
Term ended
Ended no later than Feb 17, 2018 · USPTO record
Term endedEnded no later than Feb 17, 2018USPTO record
US 6,620,416Method for treating HIV
Term ended
Ended no later than Oct 8, 2017 · USPTO record
Term endedEnded no later than Oct 8, 2017USPTO record
US 6,583,109Therapeutic polypeptides from &bgr;-hCG and derivatives
Term ended
Ended no later than Jun 24, 2017 · USPTO record
Term endedEnded no later than Jun 24, 2017USPTO record
US 6,319,504Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
Term ended
Term ended Sep 9, 2016 · USPTO record
Term endedTerm ended Sep 9, 2016USPTO record
US 6,699,656Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
Term ended
Ended no later than Jun 24, 2016 · USPTO record
Term endedEnded no later than Jun 24, 2016USPTO record
US 5,968,513Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
Term ended
Term ended no later than Oct 19, 2019 · Low confidence
Term endedTerm ended no later than Oct 19, 2019Low confidence
US 5,997,871Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
Term ended
Term ended no later than Dec 7, 2019 · Low confidence
Term endedTerm ended no later than Dec 7, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited